Resistance Surveillance Studies
Epidemiological data show that the resistance to antibiotics of many pathogens has increased in part considerably in the last 20 years. Therefore, pharmaceutical companies must provide licensing authorities with data on the frequency of occurrence of resistance to antibiotics of the relevant pathogens in the clinical indications. Such data is first required when the antibiotic is licensed and must be updated on a regular basis.
Planning, organization, carrying out and evaluation of resistance surveillance studies
Preparation of final reports of external resistance surveillance studies
Preparation of publications of the results of internal and external resistance surveillance studies